Venetoclax-Azacitidine As Salvage Therapy and Bridge to Allogeneic Cell Transplantation in Relapsed/Refractory AML Compared to Historical Data of the SAL Registry Study

被引：3
|
作者：
Unglaub, Julia M.
Schlenk, Richard F.
Hanoun, Maher
Reinhardt, H. Christian
Middeke, Jan Moritz
Schaefer-Eckart, Kerstin
Steffen, Bjoern
Krause, Stefan W.
Schliemann, Christoph
Kaufmann, Martin
Haenel, Mathias
Jost, Edgar
Crysandt, Martina
Fransecky, Lars
Kraus, Sabrina
Einsele, Hermann
Niemann, Dirk
Neubauer, Andreas
Seggewiss-Bernhardt, Ruth
Scholl, Sebastian
Klein, Stefan
Schmid, Christoph
Schaich, Markus
Platzbecker, Uwe
Baldus, Claudia D.
Bornhaeuser, Martin
Serve, Hubert
Rollig, Christoph
Kramer, Michael
Katelari, Elena
Janssen, Maike
Pabst, Caroline
Luft, Thomas
Dreger, Peter
Mueller-Tidow, Carsten
Sauer, Tim
机构：
[1] Univ Hosp Heidelberg, Dept Hematol Oncol & Rheumatol, Heidelberg, Germany
[2] Natl Ctr Tumor Dis, NCT Trial Ctr, German Canc Res Ctr, Heidelberg, Germany
[3] Univ Hosp Essen, Dept Hematol & Stem Cell Transplantat, Essen, Germany
[4] Univ Hosp Dresden, Dept Internal Med 1, Dresden, Germany
[5] Hosp Nurnberg, Dept Internal Med 5, Nurnberg, Germany
[6] Univ Hosp Frankfurt Main, Dept Hematol & Oncol, Frankfurt, Germany
[7] Univ Hosp Erlangen, Dept Hematol & Med Oncol, Erlangen, Germany
[8] Univ Hosp Muenster, Dept Med Hematol Oncol & Pneumol A, Munster, Germany
[9] Robert Bosch Krankenhaus, Dept Hematol Oncol & Palliat Med, Stuttgart, Germany
[10] Chemnitz Hosp, Dept Internal Med 3, Chemnitz, Germany
[11] Rhein Westfal TH Aachen, Univ Hosp, Fac Med, Dept Hematol Oncol Hemostaseol & Stem Cell Transp, Aachen, Germany
[12] Univ Hosp Schleswig Holstein, Dept Internal Med 2, Kiel, Germany
[13] Univ Hosp Wuerzburg, Dept Med 2, Wurzburg, Germany
[14] Ev Stift St Martin, Dept Hematol Oncol & Palliat Med, Koblenz, Germany
[15] Univ Hosp Marburg, Dept Hematol Oncol & Immunol, Marburg, Germany
[16] Sozial Stiftung Bamberg, Dept Hematol Oncol, Bamberg, Germany
[17] Univ Hosp Jena, Jena, Germany
[18] Univ Hosp Mannheim, Dept Hematol & Oncol, Mannheim, Germany
[19] Univ Hosp Augsburg, Dept Hematol & Oncol, Augsburg, Germany
[20] Rems Murr Klinikum Winnenden, Dept Hematol Oncol & Palliat Med, Winnenden, Germany
[21] Univ Hosp Leipzig, Leipzig, Germany
[22] Univ Hosp, Dept Internal Med 1, Dresden, Germany
[23] Univ Hosp Heidelberg, Internal Med Hematol Oncol & Rheumatol 5, Heidelberg, Germany
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-151287
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4418
引用
收藏
页数：7
相关论文
共 50 条
  • [31] Outcomes of Allogeneic Hematopoietic Cell Transplantation after Salvage Therapy with Blinatumomab in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia
    Salhotra, Amandeep
    Yang, Dongyun
    Mokhtari, Sally
    Al Malki, Monzr M.
    Ali, Haris
    Sandhu, Karamjeet S.
    Aribi, Ahmed
    Khaled, Samer
    Mei, Matthew
    Budde, Elizabeth
    Snyder, David
    Cao, Thai
    Spielberger, Ricardo
    Marcucci, Guido
    Pullarkat, Vinod
    Forman, Stephen J.
    Nakamura, Ryotaro
    Stein, Anthony
    Aldoss, Ibrahim
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (06) : 1084 - 1090
  • [32] Clofarabine Salvage Therapy Prior To Allogeneic Hematopoietic Stem Cell Transplantation (HCT) In Patients With Relapsed Or Refractory Acute Leukemia
    Serrano, Josefina
    Buenasmananas, Diana
    Herrera, P.
    Amigo, Mari Luz
    Calabuig, Marisa
    Martin, Eusebio
    Vidriales, Maria Belen
    de la Fuente, Adolfo
    Santero, M.
    Negri, Silvia
    Gonzalez-Campos, Jose
    Albo, Carmen
    Gonzalez, Sonia
    Rifon, Jose J.
    Viguria, M. Cruz
    Garcia-Gutierrez, V.
    Martin, Carmen
    Sanchez-Garcia, Joaquin
    BLOOD, 2013, 122 (21)
  • [33] Daratumumab Is an Effective and Safe Salvage Therapy in Relapsed/Refractory Patients with Multiple Myeloma after Allogeneic Stem Cell Transplantation
    Klyuchnikov, Evgeny
    von Pein, Ute-Marie
    Ayuk, Francis A.
    Christopeit, Maximilian
    Adjalle, Raissa
    van Randenborgh, Andre
    Wolschke, Christine
    Kroger, Nicolaus
    BLOOD, 2016, 128 (22)
  • [34] DARATUMUMAB IS AN EFFECTIVE AND SAFE SALVAGE THERAPY IN RELAPSED/REFRACTORY PATIENTS WITH MULTIPLE MYELOMA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
    Klyuchnikov, E.
    von Pein, U-M
    Ayuk, F.
    Christopeit, M.
    Adjalle, R.
    van Randenbourgh, A.
    Wolschke, C.
    Kroeger, N.
    HAEMATOLOGICA, 2017, 102 : 527 - 527
  • [35] A Retrospective Study of Venetoclax-Based Salvage Regimen As a Bridge to Allogeneic Hematopoietic Cell Transplantation (HCT) in High-Risk Acute Myeloid Leukemia (AML) Patients
    Sandhu, Karamjeet S.
    Aldoss, Ibrahim
    Yang, Dongyun
    Mokhtari, Sally
    Mei, Matthew
    Aribi, Ahmed
    Ali, Haris
    Al Malki, Monzr M.
    Salhotra, Amandeep
    Khaled, Samer K.
    Budde, Lihua E.
    Sun, Weili
    O'Donnell, Margaret
    Snyder, David S.
    Forman, Stephen J.
    Stein, Anthony S.
    Marcucci, Guido
    Nakamura, Ryotaro
    Pullarkat, Vinod
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [36] Pegaspargase, venetoclax, and nelarabine: a successful bridge to allogeneic hematopoietic stem cell transplantation in a relapsed/refractory T-cell acute lymphoblastic leukemia patient
    Kaya, Sureyya Yigit
    Bektas, Sebnem
    Askin, Abdullah Emre
    Aydin, Berrin Balik
    Mutlu, Yasa Gul
    Sevindik, Omur Gokmen
    ANNALS OF HEMATOLOGY, 2023, 102 (06) : 1599 - 1600
  • [37] Pegaspargase, venetoclax, and nelarabine: a successful bridge to allogeneic hematopoietic stem cell transplantation in a relapsed/refractory T-cell acute lymphoblastic leukemia patient
    Süreyya Yiğit Kaya
    Sebnem Bektas
    Abdullah Emre Askin
    Berrin Balık Aydın
    Yaşa Gül Mutlu
    Ömür Gökmen Sevindik
    Annals of Hematology, 2023, 102 : 1599 - 1600
  • [38] Comparison of Two Venetoclax-Based Regimens As Salvage Therapies Bridged to Allogeneic Hematopoietic Cell Transplantation in Patients with Relapsed/Refractory Acute Myeloid Leukemia
    Ye, Yiling
    Chen, Yanqiu
    Yu, Guopan
    Weng, Guangyang
    Liu, Qifa
    Jin, Hua
    BLOOD, 2023, 142
  • [39] Salvage Therapy with Allogeneic Hematopoietic Cell Transplantation For Relapsed/Refractory Aggressive B-Cell Lymphomas: A Single-Center Experience
    Doerfel, D.
    Haen, S. P.
    Vogel, W.
    Kanz, L.
    Moehle, R.
    Wirths, S.
    Faul, C.
    Bethge, W. A.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S603 - S603
  • [40] Salvage Therapy with Azacitidine Increases Regulatory T Cells in Patients with AML or MDS and Early Relapse After Allogeneic Blood Stem Cell Transplantation
    Schroeder, Thomas
    Froebel, Julia
    Cadeddu, Ron Patrick
    Czibere, Akos G.
    Dienst, Ariane
    Zipperer, Esther
    Platzbecker, Uwe
    Bug, Gesine
    Uharek, Lutz
    Fenk, Roland
    Germing, Ulrich
    Kroeger, Nicolaus
    Haas, Rainer
    Kobbe, Guido
    BLOOD, 2012, 120 (21)
12345